Ippolito Antonini

1.2k total citations
65 papers, 998 citations indexed

About

Ippolito Antonini is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Ippolito Antonini has authored 65 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Organic Chemistry, 39 papers in Molecular Biology and 21 papers in Toxicology. Recurrent topics in Ippolito Antonini's work include Cancer therapeutics and mechanisms (25 papers), Synthesis and Biological Evaluation (22 papers) and Bioactive Compounds and Antitumor Agents (21 papers). Ippolito Antonini is often cited by papers focused on Cancer therapeutics and mechanisms (25 papers), Synthesis and Biological Evaluation (22 papers) and Bioactive Compounds and Antitumor Agents (21 papers). Ippolito Antonini collaborates with scholars based in Italy, Poland and United Kingdom. Ippolito Antonini's co-authors include Sante Martelli, Paolo Polucci, Gloria Cristalli, Palmarisa Franchetti, Mario Grifantini, Francesco Claudi, Nicoletta Pescalli, Ernesto Menta, Lloyd R. Kèlland and Diego Dal Ben and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Biochemical Pharmacology.

In The Last Decade

Ippolito Antonini

64 papers receiving 960 citations

Peers

Ippolito Antonini
Ippolito Antonini
Citations per year, relative to Ippolito Antonini Ippolito Antonini (= 1×) peers Maria Giovanna Pavani

Countries citing papers authored by Ippolito Antonini

Since Specialization
Citations

This map shows the geographic impact of Ippolito Antonini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ippolito Antonini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ippolito Antonini more than expected).

Fields of papers citing papers by Ippolito Antonini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ippolito Antonini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ippolito Antonini. The network helps show where Ippolito Antonini may publish in the future.

Co-authorship network of co-authors of Ippolito Antonini

This figure shows the co-authorship network connecting the top 25 collaborators of Ippolito Antonini. A scholar is included among the top collaborators of Ippolito Antonini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ippolito Antonini. Ippolito Antonini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ben, Diego Dal, Ippolito Antonini, Michela Buccioni, et al.. (2011). Neuropeptide S Receptor: Recent Updates on Nonpeptide Antagonist Discovery. ChemMedChem. 6(7). 1163–1171. 13 indexed citations
2.
Ben, Diego Dal, Ippolito Antonini, Michela Buccioni, et al.. (2010). Molecular Modeling Studies on the Human Neuropeptide S Receptor and Its Antagonists. ChemMedChem. 5(3). 371–383. 15 indexed citations
3.
Lambertucci, Catia, Ippolito Antonini, Michela Buccioni, et al.. (2009). 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands. Bioorganic & Medicinal Chemistry. 17(7). 2812–2822. 49 indexed citations
4.
Antonini, Ippolito, et al.. (2004). Rational design, synthesis and biological evaluation of 3H-naphtho[1,2,3-de]quinoline-2,7-diones: a new class of potential antitumor agents. Polish Journal of Chemistry. 78(8). 1019–1025. 2 indexed citations
5.
Sparapani, Silvia, et al.. (2004). Synthesis and biological evaluation of indazolo[4,3-bc][1,5]naphthyridines (10-aza-pyrazolo[3,4,5-kl]acridines): a new class of antitumor agents. Bioorganic & Medicinal Chemistry. 12(22). 5941–5947. 12 indexed citations
6.
Tarasiuk, Jolanta, Olivier Seksek, Dorota Rogacka, et al.. (2004). The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines. Biochemical Pharmacology. 68(9). 1815–1823. 12 indexed citations
7.
Antonini, Ippolito, et al.. (2004). Rational Design, Synthesis, and Biological Evaluation of Bis(pyrimido[5,6,1-de]acridines) and Bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as New Anticancer Agents. Journal of Medicinal Chemistry. 47(21). 5244–5250. 43 indexed citations
8.
Antonini, Ippolito, et al.. (2003). Rational design, synthesis and biological evaluation of thiadiazinoacridines: A new class of antitumor agents. Bioorganic & Medicinal Chemistry. 11(3). 399–405. 24 indexed citations
9.
Antonini, Ippolito. (2002). DNA-binding Antitumor Agents: from Pyrimido[5,6,1-de]acridines to Other Intriguing Classes of Acridine Derivatives. Current Medicinal Chemistry. 9(18). 1701–16. 23 indexed citations
10.
Bagiński, Maciej, Paolo Polucci, Ippolito Antonini, & Sante Martelli. (2002). Binding free energy of selected anticancer compounds to DNA - theoretical calculations. Journal of Molecular Modeling. 8(1). 24–32. 17 indexed citations
11.
Antonini, Ippolito, Paolo Polucci, Lloyd R. Kèlland, et al.. (2000). N4-(ω-Aminoalkyl)-1-[(ω-aminoalkyl)amino]-4-acridinecarboxamides:  Novel, Potent, Cytotoxic, and DNA-Binding Agents. Journal of Medicinal Chemistry. 43(25). 4801–4805. 17 indexed citations
12.
Palmieri, Giovanni Filippo, et al.. (1997). Inclusion complexation of Fenofibrate with beta-cyclodextrin and hydroxypropyl beta-cyclodextrin. Evaluation of interactions in solution and solid complex characterization. Unicam Scientific Publications (University of Camerino). 7(2). 174–181. 7 indexed citations
13.
Palmieri, Giovanni Filippo, Ippolito Antonini, & Sante Martelli. (1996). Characterization and dissolution studies of PEG 4000/fenofibrate solid dispersions. Unicam Scientific Publications (University of Camerino). 6(3). 188–194. 9 indexed citations
14.
Cellai, Luciano, Patrizia Di Filippo, Mauro Iannelli, et al.. (1994). Acridine-like compounds inhibit HIV-1 reverse transcriptase by intercalating the template-primer hybrid.. 3(5). 198–201. 1 indexed citations
15.
Antonini, Ippolito, et al.. (1993). Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.. PubMed. 48(12). 1641–8. 4 indexed citations
16.
Antonini, Ippolito, et al.. (1992). Pyrimidoacridine derivatives as potential antitumor agents.. PubMed. 47(7-8). 1035–46. 2 indexed citations
17.
Antonini, Ippolito & Sante Martelli. (1992). The synthesis of a new polycyclic heterocyclic ring system: Pyrimido[5,6,1‐d,e]acridine. Journal of Heterocyclic Chemistry. 29(2). 471–473. 3 indexed citations
18.
Antonini, Ippolito, Francesco Claudi, Gloria Cristalli, et al.. (1988). Heterocyclic quinones with potential antitumor activity. 2. Synthesis and antitumor activity of some benzimidazole-4,7-dione derivatives. Journal of Medicinal Chemistry. 31(1). 260–264. 34 indexed citations
19.
Antonini, Ippolito, Francesco Claudi, Gloria Cristalli, Mario Grifantini, & Sante Martelli. (1981). Thermal decomposition of 2‐amino‐3‐aziridino‐1,4‐naphthoquinones. Journal of Heterocyclic Chemistry. 18(2). 399–404. 1 indexed citations
20.
Antonini, Ippolito, Francesco Claudi, Gloria Cristalli, et al.. (1981). N*-N*-S* Tridentate ligand system as potential antitumor agents. Journal of Medicinal Chemistry. 24(10). 1181–1184. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026